Basics |
Inotiv, Inc.
|
IPO Date: |
December 1, 1997 |
Sector: |
Healthcare |
Industry: |
Diagnostics and Research |
Market Cap: |
$87.6M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.55 | 4.57%
|
Avg Daily Range (30 D): |
$0.09 | 4.27%
|
Avg Daily Range (90 D): |
$0.17 | 6.12%
|
Institutional Daily Volume |
Avg Daily Volume: |
.37M |
Avg Daily Volume (30 D): |
.5M |
Avg Daily Volume (90 D): |
.64M |
Trade Size |
Avg Trade Size (Sh.): |
106 |
Avg Trade Size (Sh.) (30 D): |
185 |
Avg Trade Size (Sh.) (90 D): |
175 |
Institutional Trades |
Total Inst.Trades: |
202 |
Avg Inst. Trade: |
$1.41M |
Avg Inst. Trade (30 D): |
$.97M |
Avg Inst. Trade (90 D): |
$.97M |
Avg Inst. Trade Volume: |
.06M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$2.42M |
Avg Closing Trade (30 D): |
$.57M |
Avg Closing Trade (90 D): |
$.57M |
Avg Closing Volume: |
144.97K |
|
|
|
|
News |
Jun 10, 2024 @ 11:30 AM
Inotiv, Inc. Provides Business Updates
Source: Inotiv, Inc.
|
Jun 3, 2024 @ 5:24 PM
Inotiv Reaches Agreement to Resolve Previously-Ann...
Source: Inotiv, Inc.
|
May 23, 2024 @ 8:15 PM
Inotiv, Inc. to Participate in Upcoming Craig Hall...
Source: Inotiv, Inc.
|
May 9, 2024 @ 10:56 PM
Inotiv, Inc. Reschedules its Fiscal 2024 Second Qu...
Source: Inotiv, Inc.
|
May 9, 2024 @ 9:35 PM
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 ...
Source: Zacks Equity Research
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.44
|
$-.95
|
$-.73
|
Diluted EPS
|
$-.44
|
$-.95
|
$-.73
|
Revenue
|
$ 124.32M
|
$ 119.88M
|
$ 130.42M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -14.87M
|
$ -27.63M
|
$ -18.89M
|
Operating Income / Loss
|
$ -2.94M
|
$ -15.51M
|
$ -13.17M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$
|
$
|
$ 7M
|
PE Ratio
|
|
|
|
|